Contribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells

Journal of Biological Chemistry

Volumn 287, Issue 33, 2012, Pages 27396-27406

  Katsushima, Keisuke ^a   Shinjo, Keiko ^a,b   Natsume, Atsushi ^c   Ohka, Fumiharu ^a   Fujii, Makiko ^a   Osada, Hirotaka ^a,b   Sekido, Yoshitaka ^a,b   Kondo, Yutaka ^a,d  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDES; CELL TYPES; EPIGENETIC ANALYSIS; EPIGENETIC MECHANISMS; FUNCTIONAL ATTRIBUTE; GLIOBLASTOMAS; GROWTH SUPPRESSIONS; HISTOLOGICAL FEATURES; HISTONE H3; METHYLTRANSFERASES; MICROARRAY TECHNOLOGIES; MICRORNAS; MOLECULAR MECHANISM; QUANTITATIVE PCR; REGULATORY PATHWAY; THERAPEUTIC TARGETS; TISSUE HETEROGENEITY; TRIMETHYLATION; TUMOR CELLS; TUMOR HETEROGENEITY; UP-REGULATION;

AMINO ACIDS; ANTENNA LOBES; CELL PROLIFERATION; CELLS; CYTOLOGY; POLYMERASE CHAIN REACTION; RNA; TUMORS;

PROTEINS;

3 DEAZANEPLANOCIN A; ANTISENSE OLIGONUCLEOTIDE; CLAUDIN 11; HISTONE H3; LYSINE; MICRORNA; MICRORNA 1275; POLYCOMB GROUP PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EPIGENETICS; GLIOBLASTOMA; GLIOMA CELL; GLIOMA STEM LIKE CELL; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CLAUDINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOMA; HISTONES; HUMANS; MICRORNAS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; RNA, NEOPLASM;

EID: 84864992390     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.359109     Document Type: Article

References (50)

1. Bonavia, R., Inda, M. M., Cavenee, W. K., and Furnari, F. B. (2011) Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 71, 4055-4060
2. Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., Williams, P. M., Modrusan, Z., Feuerstein, B. G., and Aldape, K. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173
3. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., and Dirks, P. B. (2004) Identification of human brain tumor initiating cells. Nature 432, 396-401
4. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., Park, J. K., and Fine, H. A. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9, 391-403
5. Gupta, P. B., Chaffer, C. L., and Weinberg, R. A. (2009) Cancer stem cells: mirage or reality? Nat. Med. 15, 1010-1012
6. Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C., and Lander, E. S. (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633-644
7. Cho, R. W., Wang, X., Diehn, M., Shedden, K., Chen, G. Y., Sherlock, G., Gurney, A., Lewicki, J., and Clarke, M. F. (2008) Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26, 364-371
8. Deshpande, A. J., Cusan, M., Rawat, V. P., Reuter, H., Krause, A., Pott, C., Quintanilla-Martinez, L., Kakadia, P., Kuchenbauer, F., Ahmed, F., Delabesse, E., Hahn, M., Lichter, P., Kneba, M., Hiddemann, W., Macintyre, E., Mecucci, C., Ludwig, W. D., Humphries, R. K., Bohlander, S. K., Feuring-Buske, M., and Buske, C. (2006) Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell 10, 363-374
9. Wu, A., Oh, S., Wiesner, S. M., Ericson, K., Chen, L., Hall, W. A., Champoux, P. E., Low, W. C., and Ohlfest, J. R. (2008) Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. Stem Cells Dev. 17, 173-184
10. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
11. Gangaraju, V. K., and Lin, H. (2009) MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 10, 116-125
12. Medina, P. P., and Slack, F. J. (2008) MicroRNAs and cancer: an overview. Cell Cycle 7, 2485-2492
13. Schraivogel, D., Weinmann, L., Beier, D., Tabatabai, G., Eichner, A., Zhu, J. Y., Anton, M., Sixt, M., Weller, M., Beier, C. P., and Meister, G. (2011) CAMTA1 is a novel tumour suppressor regulated by miR-9/9&z.ast; in glioblastoma stem cells. EMBO J. 30, 4309-4322
14. Chan, J. A., Krichevsky, A. M., and Kosik, K. S. (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029-6033
15. Ernst, A., Campos, B., Meier, J., Devens, F., Liesenberg, F., Wolter, M., Reifenberger, G., Herold-Mende, C., Lichter, P., and Radlwimmer, B. (2010) Derepression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene 29, 3411-3422
16. Gillies, J. K., and Lorimer, I. A. (2007) Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle 6, 2005-2009
17. Jones, P. A., and Baylin, S. B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428
18. Bracken, A. P., and Helin, K. (2009) Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 9, 773-784
19. Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., Verhaak, R. G., Hoadley, K. A., Hayes, D. N., Perou, C. M., Schmidt, H. K., Ding, L., Wilson, R. K., Van Den Berg, D., Shen, H., Bengtsson, H., Neuvial, P., Cope, L. M., Buckley, J., Herman, J. G., Baylin, S. B., Laird, P. W., and Aldape, K. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510-522
20. Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., and Jones, P. A. (2006) Specific activation of microRNA-127 with down-regulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443
21. Cao, Q., Mani, R. S., Ateeq, B., Dhanasekaran, S. M., Asangani, I. A., Prensner, J. R., Kim, J. H., Brenner, J. C., Jing, X., Cao, X., Wang, R., Li, Y., Dahiya, A., Wang, L., Pandhi, M., Lonigro, R. J., Wu, Y. M., Tomlins, S. A., Palanisamy, N., Qin, Z., Yu, J., Maher, C. A., Varambally, S., and Chinnaiyan, A. M. (2011) Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell 20, 187-199
22. Polyak, K., and Weinberg, R. A. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273
23. Nottke, A., Colaiácovo, M. P., and Shi, Y. (2009) Developmental roles of the histone lysine demethylases. Development 136, 879-889
24. Shen, X., Liu, Y., Hsu, Y. J., Fujiwara, Y., Kim, J., Mao, X., Yuan, G. C., and Orkin, S. H. (2008) EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol. Cell 32, 491-502
25. Mohn, F., and Schübeler, D. (2009) Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet. 25, 129-136
26. Yuki, K., Natsume, A., Yokoyama, H., Kondo, Y., Ohno, M., Kato, T., Chansakul, P., Ito, M., Kim, S. U., and Wakabayashi, T. (2009) Induction of oligodendrogenesis in glioblastoma-initiating cells by IFN-mediated activation of STAT3 signaling. Cancer Lett. 284, 71-79
27. Natsume, A., Kato, T., Kinjo, S., Enomoto, A., Toda, H., Shimato, S., Ohka, F., Motomura, K., Kondo, Y., Miyata, T., Takahashi, M., and Wakabayashi, T. (2012) Girdin maintains the stemness of glioblastoma stem cells. Oncogene 31, 2715-2724
28. Kim, S. U. (2004) Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 24, 159-171
29. Kondo, Y., Shen, L., Cheng, A. S., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi-Addo, B., Gold, D. L., Sekido, Y., Huang, T. H., and Issa, J. P. (2008) Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40, 741-750
30. Kondo, Y., Shen, L., Yan, P. S., Huang, T. H., and Issa, J. P. (2004) Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. Proc. Natl. Acad. Sci. U.S.A. 101, 7398-7403
31. Gao, W., Kondo, Y., Shen, L., Shimizu, Y., Sano, T., Yamao, K., Natsume, A., Goto, Y., Ito, M., Murakami, H., Osada, H., Zhang, J., Issa, J. P., and Sekido, Y. (2008) VariableDNAmethylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis 29, 1901-1910
32. Bronstein, J. M., Tiwari-Woodruff, S., Buznikov, A. G., and Stevens, D. B. (2000) Involvement of OSP/claudin11 in oligodendrocyte membrane interactions: role in biology and disease. J. Neurosci. Res. 59, 706-711
33. Adams, B., Dörfler, P., Aguzzi, A., Kozmik, Z., Urbánek, P., Maurer-Fogy, I., and Busslinger, M. (1992) Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6, 1589-1607
34. Farah, M. H., Olson, J. M., Sucic, H. B., Hume, R. I., Tapscott, S. J., and Turner, D. L. (2000) Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development 127, 693-702
35. Letzen, B. S., Liu, C., Thakor, N. V., Gearhart, J. D., All, A. H., and Kerr, C. L. (2010) MicroRNA expression profiling of oligodendrocyte differentiation from human embryonic stem cells. PLoS ONE 5, e10480
36. Hirabayashi, Y., and Gotoh, Y. (2010) Epigenetic control of neural precursor cell fate during development. Nat. Rev. Neurosci. 11, 377-388
37. Suzuki, Y., Yamashita, R., Nakai, K., and Sugano, S. (2002) DBTSS: Data- Base of human Transcriptional Start Sites and full-length cDNAs. Nucleic Acids Res. 30, 328-331
38. Morita, K., Sasaki, H., Fujimoto, K., Furuse, M., and Tsukita, S. (1999) Claudin11/OSP-based tight junctions of myelin sheaths in brain and Sertoli cells in testis. J. Cell Biol. 145, 579-588
39. He, J., Mokhtari, K., Sanson, M., Marie, Y., Kujas, M., Huguet, S., Leuraud, P., Capelle, L., Delattre, J. Y., Poirier, J., and Hoang-Xuan, K. (2001) Glioblastomas with an oligodendroglial component: a pathological and molecular study. J. Neuropathol. Exp. Neurol. 60, 863-871
40. Homma, T., Fukushima, T., Vaccarella, S., Yonekawa, Y., Di Patre, P. L., Franceschi, S., and Ohgaki, H. (2006) Correlation among pathology, genotype, and patient outcomes in glioblastoma. J. Neuropathol. Exp. Neurol. 65, 846-854
41. Woo, C. J., Kharchenko, P. V., Daheron, L., Park, P. J., and Kingston, R. E. (2010)Aregion of the humanHOXDcluster that confers polycomb group responsiveness. Cell 140, 99-110
42. Yamagishi, M., Nakano, K., Miyake, A., Yamochi, T., Kagami, Y., Tsutsumi, A., Matsuda, Y., Sato-Otsubo, A., Muto, S., Utsunomiya, A., Yamaguchi, K., Uchimaru, K., Ogawa, S., and Watanabe, T. (2012) Polycombmediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers. Cancer Cell 21, 121-135
43. Cedar, H., and Bergman, Y. (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10, 295-304
44. Dugas, J. C., Cuellar, T. L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J. L., Foo, L. C., McManus, M. T., and Barres, B. A. (2010) Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65, 597-611
45. Shin, D., Shin, J. Y., McManus, M. T., Ptácek, L. J., and Fu, Y. H. (2009) Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann. Neurol. 66, 843-857
46. Kasinski, A. L., and Slack, F. J. (2011) MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 11, 849-864
47. Agarwal, R., Mori, Y., Cheng, Y., Jin, Z., Olaru, A. V., Hamilton, J. P., David, S., Selaru, F. M., Yang, J., Abraham, J. M., Montgomery, E., Morin, P. J., and Meltzer, S. J. (2009) Silencing of claudin11 is associated with increased invasiveness of gastric cancer cells. PLoS ONE 4, e8002
48. Awsare, N. S., Martin, T. A., Haynes, M. D., Matthews, P. N., and Jiang, W. G. (2011) Claudin11 decreases the invasiveness of bladder cancer cells. Oncol. Rep. 25, 1503-1509
49. Soini, Y., Rauramaa, T., Alafuzoff, I., Sandell, P. J., and Kärjä, V. (2010) Claudins 1, 11, and twist in meningiomas. Histopathology 56, 821-824
50. Garraway, L. A., and Sellers, W. R. (2006) Lineage dependency and lineage- survival oncogenes in human cancer. Nat. Rev. Cancer 6, 593-602